Drug abuse in cardiovascular diseases

F. Furlanello, L. Vitali Serdoz, L. De Ambroggi, R. Cappato

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

A large amount of substances and their association can lead to worsening of latent or active cardiovascular diseases and, sometimes, to ex-novo cardiovascular diseases. Negative cardiovascular effects are mainly due to pharmacokinetics of substances, in particular if drugs are administered in combination, or if intake, distribution, and elimination processes are altered; moreover, negative effects can be due to pharmacodynamics of drugs as in the presence of an interaction between an otherwise non-toxic substance and a morphofunctional altered cardiac substrate. In the first part of this chapter, we systematically describe cardiovascular effects of illicit drugs, as listed by the World Anti-Doping Agency and including different classes of substances, namely, anabolic androgenic steroids, hormones and related substances, β2-agonists, diuretics, stimulants, narcotics, cannabinoids, glucocorticosteroids, alcohol, and β-blockers. The second part is dedicated to cardiovascular effects that can occur during the use and abuse of most common prescription drugs as antipsychotic, antibiotics, anti-viral, antihistaminic, and antineoplastic drugs.

Original languageEnglish
Title of host publicationDrug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment
PublisherSpringer New York
Pages393-406
Number of pages14
Volume9781461433750
ISBN (Print)9781461433750, 1461433746, 9781461433743
DOIs
Publication statusPublished - Jul 1 2012

Fingerprint

Substance-Related Disorders
Cardiovascular Diseases
Testosterone Congeners
Prescription Drugs
Cannabinoids
Narcotics
Street Drugs
Diuretics
Pharmaceutical Preparations
Antineoplastic Agents
Antipsychotic Agents
Pharmacokinetics
Alcohols
Hormones
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Furlanello, F., Serdoz, L. V., De Ambroggi, L., & Cappato, R. (2012). Drug abuse in cardiovascular diseases. In Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment (Vol. 9781461433750, pp. 393-406). Springer New York. https://doi.org/10.1007/978-1-4614-3375-0_32

Drug abuse in cardiovascular diseases. / Furlanello, F.; Serdoz, L. Vitali; De Ambroggi, L.; Cappato, R.

Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment. Vol. 9781461433750 Springer New York, 2012. p. 393-406.

Research output: Chapter in Book/Report/Conference proceedingChapter

Furlanello, F, Serdoz, LV, De Ambroggi, L & Cappato, R 2012, Drug abuse in cardiovascular diseases. in Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment. vol. 9781461433750, Springer New York, pp. 393-406. https://doi.org/10.1007/978-1-4614-3375-0_32
Furlanello F, Serdoz LV, De Ambroggi L, Cappato R. Drug abuse in cardiovascular diseases. In Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment. Vol. 9781461433750. Springer New York. 2012. p. 393-406 https://doi.org/10.1007/978-1-4614-3375-0_32
Furlanello, F. ; Serdoz, L. Vitali ; De Ambroggi, L. ; Cappato, R. / Drug abuse in cardiovascular diseases. Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment. Vol. 9781461433750 Springer New York, 2012. pp. 393-406
@inbook{9cdb4954f5f94e48b7d88e91945a6df4,
title = "Drug abuse in cardiovascular diseases",
abstract = "A large amount of substances and their association can lead to worsening of latent or active cardiovascular diseases and, sometimes, to ex-novo cardiovascular diseases. Negative cardiovascular effects are mainly due to pharmacokinetics of substances, in particular if drugs are administered in combination, or if intake, distribution, and elimination processes are altered; moreover, negative effects can be due to pharmacodynamics of drugs as in the presence of an interaction between an otherwise non-toxic substance and a morphofunctional altered cardiac substrate. In the first part of this chapter, we systematically describe cardiovascular effects of illicit drugs, as listed by the World Anti-Doping Agency and including different classes of substances, namely, anabolic androgenic steroids, hormones and related substances, β2-agonists, diuretics, stimulants, narcotics, cannabinoids, glucocorticosteroids, alcohol, and β-blockers. The second part is dedicated to cardiovascular effects that can occur during the use and abuse of most common prescription drugs as antipsychotic, antibiotics, anti-viral, antihistaminic, and antineoplastic drugs.",
author = "F. Furlanello and Serdoz, {L. Vitali} and {De Ambroggi}, L. and R. Cappato",
year = "2012",
month = "7",
day = "1",
doi = "10.1007/978-1-4614-3375-0_32",
language = "English",
isbn = "9781461433750",
volume = "9781461433750",
pages = "393--406",
booktitle = "Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment",
publisher = "Springer New York",

}

TY - CHAP

T1 - Drug abuse in cardiovascular diseases

AU - Furlanello, F.

AU - Serdoz, L. Vitali

AU - De Ambroggi, L.

AU - Cappato, R.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - A large amount of substances and their association can lead to worsening of latent or active cardiovascular diseases and, sometimes, to ex-novo cardiovascular diseases. Negative cardiovascular effects are mainly due to pharmacokinetics of substances, in particular if drugs are administered in combination, or if intake, distribution, and elimination processes are altered; moreover, negative effects can be due to pharmacodynamics of drugs as in the presence of an interaction between an otherwise non-toxic substance and a morphofunctional altered cardiac substrate. In the first part of this chapter, we systematically describe cardiovascular effects of illicit drugs, as listed by the World Anti-Doping Agency and including different classes of substances, namely, anabolic androgenic steroids, hormones and related substances, β2-agonists, diuretics, stimulants, narcotics, cannabinoids, glucocorticosteroids, alcohol, and β-blockers. The second part is dedicated to cardiovascular effects that can occur during the use and abuse of most common prescription drugs as antipsychotic, antibiotics, anti-viral, antihistaminic, and antineoplastic drugs.

AB - A large amount of substances and their association can lead to worsening of latent or active cardiovascular diseases and, sometimes, to ex-novo cardiovascular diseases. Negative cardiovascular effects are mainly due to pharmacokinetics of substances, in particular if drugs are administered in combination, or if intake, distribution, and elimination processes are altered; moreover, negative effects can be due to pharmacodynamics of drugs as in the presence of an interaction between an otherwise non-toxic substance and a morphofunctional altered cardiac substrate. In the first part of this chapter, we systematically describe cardiovascular effects of illicit drugs, as listed by the World Anti-Doping Agency and including different classes of substances, namely, anabolic androgenic steroids, hormones and related substances, β2-agonists, diuretics, stimulants, narcotics, cannabinoids, glucocorticosteroids, alcohol, and β-blockers. The second part is dedicated to cardiovascular effects that can occur during the use and abuse of most common prescription drugs as antipsychotic, antibiotics, anti-viral, antihistaminic, and antineoplastic drugs.

UR - http://www.scopus.com/inward/record.url?scp=84948103153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948103153&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3375-0_32

DO - 10.1007/978-1-4614-3375-0_32

M3 - Chapter

SN - 9781461433750

SN - 1461433746

SN - 9781461433743

VL - 9781461433750

SP - 393

EP - 406

BT - Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment

PB - Springer New York

ER -